本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

2.55
+0.03001.19%
盘后2.50-0.0499-1.96%19:05 EDT
成交量:154.20万
成交额:388.26万
市值:1.98亿
市盈率:-0.83
高:2.61
开:2.53
低:2.45
收:2.52
数据加载中...
2022/12/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

重要事件披露

8-K - Current report
2022/12/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/27

重要事件披露

8-K - Current report
2022/10/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/30

重要事件披露

8-K - Current report
2022/09/30

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

重要事件披露

8-K - Current report
2022/06/09

重要事件披露

8-K - Current report